Skip to content

A Study on Central Transport Characteristics of Flurbiprofen Axetil in Elderly Patients

A Study on Central Transport Characteristics of Flurbiprofen Axetil in Elderly Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04128410
Enrollment
77
Registered
2019-10-16
Start date
2019-10-31
Completion date
2019-10-31
Last updated
2019-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aged, Anesthesia, Spinal, Cerebrospinal Fluid, Flurbiprofen Axetil

Keywords

S-flurbiprofen, R-flurbiprofen, cerebrospinal fluid, aged

Brief summary

The project will apply the methods of clinical observation experiment to study the central transport characteristics of flurbiprofen axetil by detecting S-flurbiprofen and R-flurbiprofen concentrations in cerebral-spinal fluid(CSF) after intravenous injection of flurbiprofen axetil in elderly patients.

Detailed description

The patients undergoing spinal anesthesia for lower extremity surgery will be studied. Flurbiprofen axetil 100mg will be injected intravenously. CSF 1ml and blood 2ml will be obtained simultaneously every 5 minutes after intravenous injection in 50 min( T1\ T10).CSF and blood samples will be used to detected S-flurbiprofen and R-flurbiprofen concentrations by using Liquid Chromatography-Mass Spectrometry. And the CSF/blood S-flurbiprofen and R-flurbiprofen concentrations ratio were calculated.

Interventions

None listed

Sponsors

Yi Feng, MD
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients undergoing lower extremity surgery under spinal or combined spinal-epidural anesthesia will be selected.

Exclusion criteria

* asthma, liver insufficiency, renal insufficiency, peptic ulcer, allergy to NSAIDs, and a history use of NSAIDs within two weeks before operation.

Design outcomes

Primary

MeasureTime frameDescription
The concentrations of S-flurbiprofen and R-flurbiprofen in plasma and CSF of all patients.perioperationThe samples will be used to be determined plasma and CSF drug concentrations.

Countries

China

Contacts

Primary ContactYi Feng, MD
yifeng65@sina.com08601088325590
Backup ContactHan Yao
yaohan2016@sina.com08601088325581

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026